SCOPUS 정보 검색 플랫폼

Volumn 23, Issue 5, 2018, Pages 947-953

Ibuprofen as a template molecule for drug design against Ebola virus

(7) Paessler, Slobodan a Huang, Cheng a Sencanski, Milan b Veljkovic, Nevena b Perovic, Vladimir b Glisic, Sanja b Veljkovic, Veljko c

a University of Texas Medical Branch School of Medicine (United States)

b UNIVERSITY OF BELGRADE (Serbia)

c Veljko Veljkovic Biomed Protection (United States)

Author keywords

Drug Repositioning; Ebola virus; Entry Inhibitors; Glycoprotein; Ibuprofen

Indexed keywords

ANTIVIRUS AGENT; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS ENVELOPE PROTEIN;

ANIMAL; CHLOROCEBUS AETHIOPS; DRUG DESIGN; DRUG EFFECT; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; METABOLISM; MOLECULAR DOCKING; PHYSIOLOGY; VERO CELL LINE; VIROLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DRUG DESIGN; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IBUPROFEN; MOLECULAR DOCKING SIMULATION; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 85047323663 PISSN: 27686701 EISSN: 27686698 Source Type: Journal
DOI: 10.2741/4627 Document Type: Article

Times cited : (19)

References (13)

1
- 84908072433
- Ebola virus disease in West Africa - The first 9months of the epidemic and forward projection
- WHO Ebola Response Team. (2014) Ebola virus disease in West Africa - The first 9months of the epidemic and forward projection. New Engl J Med DOI: 10.1056/NEJMoa1411100
- (2014) New Engl J Med

2
- 0037374498
- The price of innovation: New estimates of drug development costs
- J.A. DiMasi, R.W. Hansen, H.G. Grabowski. The price of innovation: new estimates of drug development costs. J Health Econ 22, 151–85 (2003) DOI: 10.1016/S0167-6296(02)00126-1
- (2003) J Health Econ , vol.22 , pp. 151-185
- DiMasi, J.A.¹ Hansen, R.W.² Grabowski, H.G.³

3
- 0035338343
- Risks in new drug development: Approval success rates for investigational drugs
- J.A. DiMasi. Risks in new drug development: approval success rates for investigational drugs. Clin Pharmacol Ther 69, 297–307 (2001) DOI: 10.1067/mcp.2001.115446
- (2001) Clin Pharmacol Ther , vol.69 , pp. 297-307
- DiMasi, J.A.¹

4
- 84875965830
- A systematic screen of FDA-approved drugs for inhibitors of biological threat agents
- P.B. Madrid, S. Chopra, I.D. Manger, L. Gilfillan, T.R. Keepers, A.C. Shurtleff, C.E. Green, L.V. Iyer, H.H. Dilks, R.A. Davey, A.A. Kolokoltsov, R. Carrion, J.L. Patterson, S.Bavari,R.G.Panchal,T.K.Warren,J.B.Wells, W.H. Moos, R.L. Burke, M.J. Tanga. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One 8, e60579 (2013) DOI: 10.1371/journal.pone.0060579
- (2013) PLoS One , vol.8
- Madrid, P.B.¹ Chopra, S.² Manger, I.D.³ Gilfillan, L.⁴ Keepers, T.R.⁵ Shurtleff, A.C.⁶ Green, C.E.⁷ Iyer, L.V.⁸ Dilks, H.H.⁹ Davey, R.A.¹⁰ Kolokoltsov, A.A.¹¹ Carrion, R.¹² Patterson, J.L.¹³ Bavari, S.¹⁴ Panchal, R.G.¹⁵ Warren, T.K.¹⁶ Wells, J.B.¹⁷ Moos, W.H.¹⁸ Burke, R.L.¹⁹ Tanga, M.J.²⁰ more..

5
- 84924964870
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
- 5. J. Kouznetsova, W. Sun, C. Martinez-Romero, G. Tawa, P. Shinn, C.Z. Chen, A. Schimmer, P. Sanderson, J.C. McKew, W. Zheng, A. Garcia-Sastre. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerging Microbes and Infections 3, e84 (2014) DOI: 10.1038/emi.2014.88
- (2014) Emerging Microbes and Infections , vol.3 , pp. e84
- Kouznetsova, J.¹ Sun, W.² Martinez-Romero, C.³ Tawa, G.⁴ Shinn, P.⁵ Chen, C.Z.⁶ Schimmer, A.⁷ Sanderson, P.⁸ McKew, J.C.⁹ Zheng, W.¹⁰ Garcia-Sastre, A.¹¹

6
- 84925004394
- Virtual screening for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection
- V. Veljkovic, P.M. Loiseau, B. Figadere, S. Glisic, N. Veljkovic, V.R. Perovic, D.P. Cavanaugh, D.R. Branch. Virtual screening for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection. F1000Res 4, 34 (2015) DOI: 10.12688/f1000research.6110.1
- (2015) F1000Res , vol.4 , pp. 34
- Veljkovic, V.¹ Loiseau, P.M.² Figadere, B.³ Glisic, S.⁴ Veljkovic, N.⁵ Perovic, V.R.⁶ Cavanaugh, D.P.⁷ Branch, D.R.⁸

7
- 83455201155
- The role of long-range intermolecular interactions in discovery of new drugs
- N. Veljkovic, S. Glisic, V. Perovic, V. Veljkovic. The role of long-range intermolecular interactions in discovery of new drugs. Exp Opin Drug Disc 6, 1263 (2011). DOI: 10.1517/17460441.2012.638280
- (2011) Exp Opin Drug Disc , vol.6 , pp. 1263
- Veljkovic, N.¹ Glisic, S.² Perovic, V.³ Veljkovic, V.⁴

8
- 84938943006
- Improving attrition rates in ebola virus drug discovery
- S. Glisic, S. Paessler, N. Veljkovic, V.R. Perovic, J. Prljic, V. Veljkovic. Improving attrition rates in ebola virus drug discovery. Exp Opin Drug Disc 10, 1025–1032 (2015) DOI: 10.1517/17460441.2015.1062872
- (2015) Exp Opin Drug Disc , vol.10 , pp. 1025-1032
- Glisic, S.¹ Paessler, S.² Veljkovic, N.³ Perovic, V.R.⁴ Prljic, J.⁵ Veljkovic, V.⁶

9
- 84936952565
- In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
- V. Veljkovic, M. Goeijenbier, S. Glisic, N. Veljkovic, V. Perovic, M. Sencanski, D.R. Branch, S. Paessler. In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease. F1000Res 4, 104 (2015) DOI: 10.12688/f1000research.6110.1
- (2015) F1000Res , vol.4 , pp. 104
- Veljkovic, V.¹ Goeijenbier, M.² Glisic, S.³ Veljkovic, N.⁴ Perovic, V.⁵ Sencanski, M.⁶ Branch, D.R.⁷ Paessler, S.⁸

10
- 84978437369
- Toremifene interacts with and destabilizes the Ebola virus glycoprotein
- Y. Zhao, J. Ren, K. Harlos, D.M. Jones, A. Zeltina, T.A. Bowden, S. Padilla-Parra, E.E. Fry, D.I. Stuart. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535, 169–172 (2016) DOI: 10.1038/nature18615
- (2016) Nature , vol.535 , pp. 169-172
- Zhao, Y.¹ Ren, J.² Harlos, K.³ Jones, D.M.⁴ Zeltina, A.⁵ Bowden, T.A.⁶ Padilla-Parra, S.⁷ Fry, E.E.⁸ Stuart, D.I.⁹

11
- 4043162793
- VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
- A. Pedretti, L. Villa, G. Vistoli. VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput Aided Mol Des 18, 167–73 (2004) DOI: 10.1023/B:JCAM.0000035186.90683.f2
- (2004) J Comput Aided Mol Des , vol.18 , pp. 167-173
- Pedretti, A.¹ Villa, L.² Vistoli, G.³

12
- 70349932423
- Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity
- G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A.J. Olson. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem 30, 2785–91 (2009) DOI: 10.1002/jcc.21256
- (2009) J Comput Chem , vol.30 , pp. 2785-2791
- Morris, G.M.¹ Huey, R.² Lindstrom, W.³ Sanner, M.F.⁴ Belew, R.K.⁵ Goodsell, D.S.⁶ Olson, A.J.⁷

13
- 76149120388
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading
- O. Trott, A.J. Olson. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31, 455–461 (2010) DOI: 10.1002/jcc.21334
- (2010) J Comput Chem , vol.31 , pp. 455-461
- Trott, O.¹ Olson, A.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.